CXL Ophthalmics

CXL Ophthalmics is developing a minimally invasive treatment for ectatic corneal diseases, offering early intervention for millions of patients worldwide. Our EpiSmart approach is a transformative cross-linking system designed to treat keratoconus without disrupting the epithelium, allowing for rapid resumption of normal eye activity.